Development and Optimization of Serum-free and Protein-free Media

Medicines from Animal Cell Culture

Volumn , Issue , 2007, Pages 29-44

  Jayme, David W ^a  

^a BRIGHAM YOUNG UNIVERSITY HAWAII   (United States)

Author keywords

Cyclodextrin solubilization; Facilitating yield improvement and downstream purification; Serum free and protein free formulations; Serum free and protein free media; Serum supplemented culture systems and verifying comparability

Indexed keywords

EID: 84859947811     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470723791.ch3     Document Type: Chapter

References (37)

1. Altman PL, Dittmer DS (1961) Blood and Other Body Fluids. Federation of American Societies for Experimental Biology, Bethesda.
2. Barnes DW, Sirbasku DA, Sato GH (1984) Cell Culture Methods for Molecular and Cell Biology. AR Liss, New York; Vol. 1-4.
3. Castle P, Robertson JS (1999) 'Summary and Conclusion'. In Animal Sera, Animal Sera Derivatives and Substitutes Used in the Manufacture of Pharmaceuticals: Viral Safety and Regulatory Aspects, Dev. Biol. Stand., Karger, Basel; Vol. 99, 191-196.
4. Fike R, Dadey B, Hassett R, Radominski R, Jayme D, Cady D (2001) Cytotechnology; 36: 33-39.
5. Fike R, Kubiak J, Price P, Jayme D (1993) BioPharm Int; 6(8): 49-54.
6. Freshney RI (2000) Culture of Animal Cells: A Manual of Basic Technique, fourth edition. AR Liss, New York.
7. Gorfien SF, Paul W, Judd D, Tescione L, Jayme DW (2003) Biopharm Int. 16(4): 34-38.
8. Gorfien SF, Paul W, Walowitz J, Keem R, Biddle W, Jayme D (2000) Biotechnol. Prog.; 16: 682-687.
9. Ham RG, McKeehan WL (1979) Meth. Enzymol.; 58: 44-93.
10. ICH Harmonized Tripartite Guideline Q5E (2003) Comparability of biotechnological/biological products subject to changes in their manufacturing processes.(see www.och.org).
11. ICH Harmonized Tripartite Guideline Q7A (2000) Good manufacturing practice guide for active pharmaceutical ingredients.(see www.ich.org).
12. Jayme DW (1991) Cytotechnology; 5: 15-30.
13. Jayme DW (1999) In Animal Sera, Animal Sera Derivatives and Substitutes Used in the Manufacture of Pharmaceuticals: Viral Safety and Regulatory Aspects, Dev. Biol. Stand., Karger, Basel; Vol. 99, 181-187.
14. Jayme DW, Blackman KE (1985) In Advances in Biotechnological Processes. Eds Mizrahi A, van Wezel AL. Vol. 5, 1-30.
15. Jayme DW, Gruber DF (1998), In Cell Biology: A Laboratory Handbook. Academic Press, San Diego; Vol 1, 19-26.
16. Jayme DW, Smith SR (2000) Cytotechnology; 33: 27-35.
17. Jayme DW, DiSorbo DM, Kubiak JM, Fike RM (1992) In Animal Cell Technology: Basic and Applied Aspects. Eds Murakami H, Shirahata S and Tachibana H. Kluwer, Dordrecht; Vol 4, 143-148.
18. Jayme DW, Kubiak JM, Battistoni, Cady DJ (1996) Cytotechnology; 22: 255-261.
19. Jayme D, Kubiak J, Fike R, Rashbaum S, Smith S (1998) In Animal Cell Technology: Basic and Applied Aspects. Kluwer, Dordrecht; Vol 9, 223-227.
20. Jayme DW, Price PJ, Plavsic MZ, Epstein DA (1999) In Animal Cell Technology: Products from Cells, Cells as Products. Kluwer, Dordrecht; 459-461.
21. Jayme D, Fike R, Radominski R, Dadey B, Hassett R, Cady D (2002) In Animal Cell Technology: Basic and Applied Aspects. Kluwer, Dordrecht; 12: 155-159.
22. Kadouri A, Spier RE (1997) Cytotechnology; 24: 89-98.
23. Lobo-Alfonso J, Price P, Jayme D (in press) In Protein Hydrolysates in Nutrition and Biotechnology. Ed Pasupuleti VK. Springer, Dordrecht.
24. Mather JP (1998) In Animal Cell Culture Methods. Eds Mather JP, Barnes D. Academic Press, San Diego.
25. Murakami H, Shimomura T, Nakamura T, Ohashi H, Shinohara K, Omura H (1984) J. Agricult. Chem. Soc. Japan; 56: 575-583.
26. Nestler LL, Evege EK, McLaughlin JA et al. (2004) Quest; 1: 42-47.
27. Oxender DL, Christensen HN (1963) Nature; 197: 765-767.
28. Peppers SC, Talley DL, Loke HN, Caple MV (2002) IBC Eighth International Conference on Antibody Production and Downstream Processing.
29. Radominski R, Hassett R, Dadey B, Fike R, Cady D, Jayme D (2001) BioPharm; 14(7): 34-39.
30. Spier RE (1983) In Advances in Biotechnological Processes. AR Liss, New York, Vol. 2.
31. Taylor WG (1984) In Vitro; 20: 58-70.
32. Vogel JH, Prtischet M, Wolfgang J, Wu P, Konstantinov K (2001) In Animal Cell Technology: From Target to Market. Kluwer, Dordrecht.
33. Walowitz JL, Fike RM, Jayme DW (2003) Biotechnol. Prog.; 19: 64-68.
34. Wang RJ (1976) In Vitro; 12: 19-22.
35. Waymouth C (1972) In Growth, Nutrition, and Metabolism of Cells in Culture. Eds Rothblat GH, Cristofalo VJ. Academic Press, New York.
36. Young FB, Sharon WS, Long RB (1966) In Biochemical Engineering. Eds Constantinides A, Wieth WR, Subramanian KV. NY Academy of Science USA; 369: 108.
37. Zielke HR, Ozand PT, Tildon JT, Sevdalian DA, Cornblath M (1978) J. Cell Physiol.; 95: 41-48.